Program Committee
Continuing Education
Exhibits and Sponsorship
Special Interest Section Meetings

2021 Virtual Annual Scientific Meeting (63rd)


Update: AHS leadership has made the difficult yet necessary decision to conduct the 63rd Annual Scientific Meeting virtually. The virtual meeting starts June 3, 2021 and will feature live-streamed sessions, live Q&A and pre-recorded lectures available on demand. For additional details, please view the meeting FAQ here.

Register Today


The Annual Scientific Meeting is designed for physicians, psychologists, scientists, researchers, physician assistants, nurse practitioners, and other health professionals involved in the care of patients with head, neck, and orofacial pain.

AHS has dedicated over 60 years to leading and serving the headache community.

THE AMERICAN HEADACHE SOCIETY’S® ANNUAL SCIENTIFIC MEETING continues to be the premiere venue for the dissemination of the latest and most up-to-date research and scientific advances underlying the practice of Headache Medicine.


The American Headache Society® wishes to take steps to ensure that no individual with disability is excluded, denied services, segregated, or otherwise treated differently than other individuals because of the absence of auxiliary aids and services. If you need any auxiliary aids or services identified in the Americans with Disabilities Act, or any assistance in registering for this symposium, please contact AHS Meeting Manager, Heidi Jetter at 856-423-0043, write to her at AHS, 19 Mantua Road, Mt. Royal, NJ, 08061, or email AHSHQ@talley.com.


2021 Virtual Annual Scientific Meeting (63rd)




Amynah Pradhan, PhD


Jessica Ailani, MD, FAHS

Mark J. Burish, MD, PhD

Catherine D. Chong, PhD, FAHS

Deborah I. Friedman, MD, MPH, FAHS

Todd J. Schwedt, MD, MSCI, FAHS

Elizabeth Seng, PhD, FAHS

Christina L. Szperka, MD, FAHS


2021 Virtual Annual Scientific Meeting (63rd)



At the conclusion of this meeting, attendees should be better able to:

  • Explain fundamental mechanisms of headache disorders and how they relate to new therapies
  • Apply an understanding of established and newly introduced therapies to clinical practice
  • Become aware of how headache disorders affect cognitive function
  • Identify the role of sex and gender in headache disorders


The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


The American Headache Society® designates this Other activity (live and recorded content) for a maximum of  30.00 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.


  • Attend sessions for which credit is sought in full (this includes watching on-demand courses).
  • Complete the post-activity evaluation.
  • A certificate of completion will be available once the evaluation is submitted.


The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.


The American Headache Society® received funding to support this activity from the following organizations:

AbbVie Inc.
Lilly USA, LLC
Lundbeck LLC


2021 Virtual Annual Scientific Meeting (63rd)


2021 Virtual Annual Scientific Meeting Preliminary Program Agenda*

*All presentation titles and times are tentative and subject to change. Please plan to log in 10 minutes ahead of each start time to hear important welcome announcements.

For a complete list of on demand poster presentations, please click here.

Thursday, June 3, 2021 | 10:00 am – 2:00 pm EDT
Live Session with Q&A
Hot Topics in Basic Science Symposium – Part 1

Moderators: Rami Burstein, PhD, Harvard Medical School and Amynah Pradhan, PhD, University of Illinois at Chicago

10:00 AM – 10:20 AM

Interrogating CNS Circuits in Headache and Pain Relief

K.C. Brennan, MD, FAHS, University of Utah

10:20 AM – 10:25 AM


10:25 AM – 10:45 AM

Translational Significance of the Nitroglycerin Model

Peter J. Goadsby, MD, PhD, FAHS, UCLA

10:45 AM – 10:50 AM


10:50 AM – 11:10 AM

Modulation of Inhibitory Descending Pain Pathway: Insights into Migraine Pathology and Treatment

Paul Durham, PhD, Missouri State University 

11:10 AM – 10:15 AM


11:15 AM – 11:30 AM


Hot Topics in Basic Science Symposium – Part 2

Moderators: Rami Burstein, PhD, Harvard Medical School and Amynah Pradhan, PhD, University of Illinois at Chicago

11:30 AM – 11:50 AM

Imaging Migraine Progression

Catherine Chong, PhD, FAHS, Mayo Clinic

11:50 AM – 11:55 AM


11:55 AM – 12:15 PM

Sexual Dymorphism in Post-Traumatic Headache

Dan Levy, PhD, MSc, BIDMC

12:15 PM – 12:20 PM


12:20 PM – 12:40 PM

Voltage Gated Calcium Channels in Migraine

Yu-Qing Cao, PhD, Washington University Pain Center 

12:40 PM – 12:45 PM


12:45 PM – 1:00 PM

Q&A including Part 1 and Part 2 Panelists

1:00 PM – 1:10 PM


Data Blitz
1:10 PM – 1:15 PM

CGRP Antibody Rescues Tactile Sensitization Induced by Mild Traumatic Brain Injury in Mice

Anne-Sophie Wattiez, PhD, University of Iowa

1:15 PM – 1:20 PM

Perivascular CGRP Actions in a Mouse Model of Migraine

Louis K. Balcziak, BA, University of Iowa

1:20 PM – 1:25 PM

Plasma Lipolysis and Desaturase Activity Contribute to Chronic Migraine Pathology

Alfred N. Fonteh, PhD, Huntington Medical Research Institutes

1:25 PM – 1:30 PM

Characterization of Cerebrospinal Fluid Phospholipase A2 Isoforms That Increase in Episodic Migraine

Alfred N. Fonteh, PhD, Huntington Medical Research Institutes

1:30 PM – 1:35 PM

Non-steroidal Anti-inflammatory Drugs Attenuate Plasma Lipolysis in Chronic Migraine

Alfred N. Fonteh, PhD, Huntington Medical Research Institutes

1:35 PM – 1:40 PM

Evaluation of Novel Non-opioid, Non-addictive Therapeutics in the NINDS HEAL Initiative Preclinical Screening Platform for Pain

Smriti Iyengar, PhD, NINDS/NIH

1:40 PM – 2:00 PM

Panel Discussion including Data Blitz Panelists/Q&A/Closing Remarks

Friday, June 4, 2021 | 10:00 am – 1:35 pm EDT
Live-streamed Session with Live Q&A

Keynote Presentations
10:00 AM – 10:30 AM

Genes, Stress and Resilience

Huda Akil, PhD, University of Michigan

10:30 AM – 11:00 AM

Diversity and Inclusion: How We Can Learn from Others to Improve Diversity in Headache Research

Richard Benson, MD, PhD, NINDS/NIH

11:00 AM – 11:15 AM


11:15 AM – 11:25 AM


Plenary I: Hot Topics in Headache
11:25 AM – 11:40 AM

Role of CGRP in Infection-induced Pain

Isaac M. Chiu, PhD, Harvard University

11:40 AM – 11:55 AM

Vaccines and Their Impact on Migraine Treatment

Amy A. Gelfand, MD, FAHS, UCSF Weill Institute for Neurosciences

Debate: Should ICHD Maintain Chronic Migraine as a Separate Diagnosis from Migraine
12:10 PM – 12:30 PM


David W. Dodick, MD, FAHS, Mayo Clinic


Andrew D. Hershey, MD, PhD, FAHS, Cincinnati Children’s Hospital Medical Center

12:30 PM – 12:40 PM


12:40 PM – 12:50 PM


Debate: The ICHD-3 Criteria for TTHA Should be Changed
12:50 PM – 1:10 PM


Deborah I. Friedman, MD, MPH, FAHS, UT Southwestern Medical Center


Morris Levin, MD, FAHS, UCSF Headache Center

1:10 PM – 1:20 PM


1:20 PM – 1:35 PM

Closing Remarks

2:00 PM – 3:00 PM

Talent Show

Saturday, June 5, 2021 | 10:00 am – 1:40 pm EDT
Live-streamed Session with Live Q&A

Plenary II: Thinking Through the Pain of Migraine: Cognitive Findings, Neuroimaging and Behavioral Strategies

Moderators: Elizabeth Seng, PhD, FAHS, Yeshiva University/Albert Einstein College of Medicine and Alexandra C. Ross, PhD, University of California San Francisco

10:00 AM – 10:20 AM

Cognition and Pain Processing

Tim Salomons, PhD, Queens University

10:20 AM – 10:40 AM

Cognitive Dysfunction and Migraine

Raquel Gil-Gouveia, MD, PhD, Hospital de Luz

10:40 AM – 11:00 AM

Cognitive Strategies and Migraine

David Seminowicz, PhD, University of Maryland

11:00 AM – 11:15 AM


11:15 AM – 11:30 AM


Plenary III: Cortical Spreading Depression and Headache

Moderators: Catherine D. Chong, PhD, FAHS, Mayo Clinic and Amynah Pradhan, PhD, University of Illinois at Chicago

11:30 AM – 11:50 AM

Relationship Between CSD and Sleep

Andrew Charles, MD, FAHS, University of California, Los Angeles

11:50 AM – 12:10 PM

CSD Can Evoke Anxiety and Pain

Andrea Harriott, MD, PhD, Massachusetts General Hospital

12:10 PM – 12:30 PM

CSD Evocation (Clinical base)

Messoud Ashina, MD, PhD, Glostrup Hospital

12:30 PM – 12:45 PM


12:45 PM – 12:55 PM


Harold G. Wolff Award Lecture
12:55 PM – 1:10 PM

Chronic versus Episodic Migraine: The 15-day Threshold Does Not Adequately Reflect Substantial Differences in Disability Across the Full Spectrum of Headache Frequency

Ryotaro Ishii, MD, PhD, Mayo Clinic

1:10 – 1:25 PM


1:25 PM – 1:40 PM

Closing Remarks

2:00 PM – 3:00 PM

Membership Meeting*

*All registered AHS members have been pre-registered for the webinar. A link will be sent separately to access this event.

Sunday, June 6, 2021 | 10:00 am – 12:10 pm EDT
Live-streamed Session with Live Q&A

Plenary IV: Sex, Gender Specific Differences in Headache
10:00 AM – 10:20 AM

Sex Differences in Pain: From Nociceptor to Brain

Gregory Dussor, PhD, University of Texas at Dallas

10:20 AM – 10:40 AM

Does Sex/Gender Impact the Brain’s Activation Patterns in Pain?

Nasim Maleki, PhD, Harvard Medical School

10:40 AM – 11:00 AM

Does Gender Impact the Presentation of Headache Disorders, Response to Treatment, and Adherence; Learnings from Clinic

Anna Pace, MD, Mt. Sinai Hospital

11:00 AM – 11:15 AM


11:15 AM – 11:25 AM


Early Career Award Lecture
11:25 AM – 11:40 AM

Learning the Full Impact of Migraine Through Patient Voices: Results of a Qualitative Study

Rebecca Erwin Wells, MD, MPH, FAHS, Wake Forest University Baptist Medical Center

11:40 AM – 11:55 AM


11:55 AM – 12:10 PM

Closing Remarks

On-Demand Content

For a complete list of on demand poster presentations, please click here.

Special Interest Section Symposium
Life in a Pandemic- A Window into the Life of a Person with Migraine 

Presented by Migraine and Women’s Health Section

Window into the Life of a Person with Migraine- using the Pandemic to Highlight the Social Isolation of a Person with Chronic Migraine

Deena E. Kuruvilla, MD, FAHS, Westport Headache Institute

Direct From the Patient; The Lived Experience of Migraine During the Global Pandemic

Dawn C. Buse, PhD, FAHS, Albert Einstein College of Medicine

The Legal Aspects of Dealing with Migraine – Workplace Issues

Nina Riggins, MD, PhD, University of California, San Francisco

Caring for Migraine Patients Amidst a Global Pandemic – A Provider Perspective

Carolyn Bernstein, MD, FAHS, Harvard Medical School

A Pain in the Neck: Interventional and Physical Therapy Approaches to Neck Pain in Adult and Pediatric Populations with Headache and Temporomandibular Disorders

Presented by Procedural Headache Medicine Section, TMD, Cervical Spine, and Orofacial Pain Section

Interventional Approaches to Headache with Associated Neck Pain

Jason W. Siefferman, MD, Manhattan Pain Medicine, PLLC

Management of Pediatric Headache with Associated Neck Pain

Chaouki Khoury, MD, MS, FAHS, Atlanta Headache Specialists

The Relationship of TMD with Cervical Pain and Headache Disorders

Antonia Teruel, DMD, MS, PhD, Head Pain Institute

Physical Therapy Modalities for the Treatment of Headache, Neck Pain, and Temporomandibular Disorders

Danielle Messier, MSPT, DPT, Cert MDT, Hartford Healthcare Rehabilitation Network

Interpreting Current Evidence on Diet and Physical Activity in Migraine for Clinical Practice

Presented by Behavioral Issues, Co-sponsored by the Methodology, Design, and Statistical Issues Section and the Complementary and Integrative Medicine Section 

Physiological Mechanisms by Which Exercise Influences Migraine

Megan Irby, PhD, Wake Forest Baptist Medical Center

Move More, Sit Less: Managing Migraine by Making Physical Activity a Part of Daily Life

Dale S. Bond, PhD, The Miriam Hospital/Brown Alpert Medical School Weight Control and Diabetes Research Center

Dietary Considerations for Migraine

Margaret Slavin, PhD, RDN, George Mason University

Health Equity and Inclusion in Headache Medicine 

Presented by New Investigators and Trainees Section & Underserved Population Section

A Population Health Approach to Migraine

Joanna Kempner, PhD, Rutgers University

Structural Competency and Headache: Observations from a Bronx Academic Center

Cynthia E. Armand, MD, Albert Einstein College of Medicine

Providing Care to Rural Native Americans

Michael Stitzser, MD, Winsow Indian Heath Care Center

Reaching Out: Treating Underserved Populations

Charles C. Flippen II, MD, David Geffen School of Medicine at UCLA

The Headache Pipeline

Larry Charleston IV, MD, MSc, FAHS, Michigan State University

Research and Underserved Populations

Megan Irby, PhD, Wake Forest Baptist Medical Center

Scientific Abstract Presentations
Amylin Induces Migraine-Like Behaviors in Mice

Levi P. Sowers, PhD, University of Iowa

Neuronal Complexity Is Attenuated in Chronic Migraine and Restored by HDAC6 Inhibition

Zachariah J. Bertels, PhD, University of Illinois at Chicago

Analyzing Serum CGRP Levels and Inflammatory Markers in Chronic Migraine in Comparison to Episodic Migraine and Healthy State

Mansoureh Togha, Tehran University of Medical Sciences

PACAP-induced Cephalic Allodynia Is Inhibited by Delta Opioid Receptor Activation

Elizaveta Mangutov, BS, University of Illinois at Chicago

Transient Blood Brain Barrier Opening During Cortical Spreading Depression Results from Dynamic Reorganization of the Tight Junction Protein Claudin 5

Jared Wahl, MPH, University of Arizona

The Role of Cerebellar CGRP in Migraine-like Behavior

Mengya Wang, University of Iowa

Links Between Functional NHE1 Expression at the Blood Brain Barrier, HSP90 and Sumatriptan Blood to Brain Uptake

Seph Palomino, BS, University of Arizona

Transcriptional and Epigenomic Comparison of Human and Mouse Trigeminal Ganglia at Single-cell Resolution

Lite Yang, BS, Brigham and Women’s Hospital

Spatial Aspects of Pain Modulation in Adolescents with Migraine

Hadas Nahman-Averbuch, PhD, Cincinnati Children’s Hospital

Impact of Abuse on Migraine Hypersensitivity Symptoms: Results from the American Registry for Migraine Research (ARMR)

Meesha Trivedi, BS, Mayo Clinic

Reasons for Hesitating to Consult for Migraine Care: Results of the OVERCOME (US) Study

Robert E. Shapiro, MD, PhD, Larner College of Medicine, University of Vermont

Characterizing Preventive Treatment Gaps in Migraine: Results from the CaMEO Study

Stephanie J. Nahas, MD, MDEd, Thomas Jefferson University

Suicide Attempt Incidence and Psychiatric Comorbidities in Veterans with Chronic Head, Neck and Back Pain from 2001-2010: Trends and Associations

X. Michelle Androulakis, MD, FAHS, University of South Carolina

Pediatric Ischemic Stroke and Migraine: The Conundrum of Association!

Anna McDonnell, University of Mississippi Medical Center

Patient Experience of Telemedicine for Headache Care During the COVID-19 Pandemic: An American Migraine Foundation Survey Study

Chia-Chun Chiang, MD, Mayo Clinic

Assessment of Cognitive Interference in Migraine: Results of the MiCOAS Qualitative Study

Maya Gerstein, DrPH, PHarmerit – An Open Health Company

Is Post-Traumatic Headache in Veterans Different Than Traumatic Brain Injury with Headache?

John Ney, MD, MPH, VA Connecticut Healthcare System, Headache Centers of Excellence Research & Evaluation Center

Differentiating Between Migraine and Post-traumatic Headache with a Machine Learning Classifier

Gina Dumkrieger, PhD, Mayo Clinic

White Matter Hyperintensities in Patients with Migraine

Catherine Chong, PhD, Mayo Clinic

Central Sensitization and Migraine Treatments Impact on Thalamic Metabolism: MR Study at 21.1 T

Samuel Holder, BS, Florida State University

Patterns of Medical Cannabis Use and Strain Analysis Among Patients with Migraine and Headache in a Medical Cannabis Cohort; A Follow-Up Study

Eric P. Baron, DO, Cleveland Clinic

A Survey of the Most Common Drugs Causing Headaches in FDA Adverse Event Reporting System

Brett Musialowicz, BA, Rutgers Robert Wood Johnson Medical School

Estimating the Probability of Reported versus Theoretical Drug-Drug Interactions in Headaches Medicine

Victor Kaytser, MD, Rutgers Robert Wood Johnson Medical School

Effectiveness of Mindfulness Meditation vs. Headache Education for Adults with Migraine: A Randomized Clinical Trial

Rebecca E. Wells, MD, MPH, FAHS, Wake Forest School of Medicine

Industry-submitted Abstract Presentations
Effect of Galcanezumab on Migraine Headache Days in Women with Menstrual Migraine: A Post Hoc Analysis

E. Anne MacGregor, MBBS, MSc, MD, St. Bartholomew’s Hospital

A Phase 3 Randomized, Double-blind, Sham-controlled Trial of e-TNS for the Acute Treatment of Migraine (TEAM)

Deena E. Kuruvilla, MD, VA Connecticut Healthcare System, Headache Centers of Excellence Research & Evaluation Center

A Phase 2 Study of Fremanezumab as a Treatment for Posttraumatic Headache in Adult Patients

Egilius L.H. Spierings, MD, PhD, Medvadis Research Corporation

Efficacy and Safety of AXS-07 (MoSEIC™ Meloxicam/Rizatriptan) in the Acute Treatment of Migraine: Results from the INTERCEPT Phase 3 Randomized, Double-blind, Placebo-controlled Trial

Amanda Jones, PharmD, Axsome Therapeutics Inc.

Noninvasive Combined Occipital and Trigeminal Nerve Stimulation for Treatment of Migraine – a Multi-Center, Randomized, Sham-Controlled Pivotal Study

Stewart J. Tepper, MD, FAHS, Geisel School of Medicine at Dartmouth

Real-World Evidence for Control of Patients with Chronic Migraine Who Received Calcitonin Gene‒Related Peptide Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment

Andrew Blumenfeld, MD, Headache Center of Southern California

Atogepant Significantly Reduces Mean Monthly Migraine Days in the Phase 3 Trial (ADVANCE) for the Preventive Treatment of Migraine

Jessica Ailani

Risk of Hypertension in Erenumab-treated Patients with Migraine in Clinical Trials and in the Postmarketing Setting

David W. Dodick, MD, FAHS, Mayo Clinic

Rapid Resolution of Migraine Symptoms After Initiating the Preventive Treatment Eptinezumab During a Migraine Attack

Jessica Ailani, MD, FAHS, MedStar Georgetown University Hospital

Combining UbRogepAnt and Preventives for MiGrainE (COURAGE) Study Using the Migraine Buddy Application: A Novel, Entirely Remote Design for Collecting Real-world Evidence

Richard B. Lipton, MD, FAHS, Albert Einstein College of Medicine

Intranasal Zavegepant Is Effective and Well Tolerated for the Acute Treatment of Migraine: A Phase 2/3 Dose-Ranging Clinical Trial

Robert Croop, MD, Biohaven Pharmaceuticals, Inc.

A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine

Robert Croop, MD, Biohaven Pharmaceuticals, Inc.

Late-breaking Abstract Presentations
Migraine Is Associated With Higher Incidence of COVID-19, and Higher Frequency of COVID-19 Symptoms, but Lower COVID-19-Associated Health Care Resource Utilization Rates

Robert E. Shapiro, MD, PhD, FAHS, University of Vermont

Pediatric Headache Experience During the COVID-19 Pandemic

Marc DiSabella, DO, Children’s National Medical Center

NIH Roadmap for Migraine Research Update
NIH Roadmap for Migraine Research Update

Michael L. Oshinsky, PhD, The National Institute of Neurological Disorders and Stroke

Seymour Solomon Award Lecture
What Is…”Getting Better?”

Scott W. Powers, PhD, ABPP, FAHS

John R. Graham Award Lecture
Practicing Headache Medicine in 2021: Realities on the Ground

Deborah I. Friedman, MD, MPH, FAHS

Future of Headache Medicine Presentations
Disconnectome of the Migraine Brain: A Model of Migraine as “connectopathy”

Marcello Silvestro, MD, University of Campania “Luigi Vanvitelli”

Simultaneous Comparisons of 22 Acute Migraine Medications: A Big Data Analysis of 10 Million Patient Self-reported Treatment Records from a Migraine Smartphone Application

Xuemin Fang, PhD, Graduate School of Health Innovation/Kanagawa University of Human Services

International Headache Academy Research Award Presentations
Visual Evoked Potentials as a Biomarker for Persistent Post-traumatic Headache

Carlyn A. Patterson Gentile, MD, PhD, Children’s Hospital of Philadelphia

How Does Headache Treatment Help? Identification of Patient-valued Outcome Measures in Adolescents with Continuous Headache

Kaitlin A. Greene, MD, Oregon Health & Science University

Data Cartography to Understand Local, Regional and Provincial Patterns of Headache Diagnosis, Treatment and Health Resource Utilization in Alberta, Canada

Thilinie Rajapakse, MD, FRCPC, University of Alberta/Stollery Children’s Hospital

Characterization of Molecular Adaptations Within Trigeminal Dural Afferents in Response to Head Pain

William Renthal, MD, PhD, Harvard Medical School

Frontiers in Headache Research Award Platform Presentations
Self-Administered At-Home Sphenopalatine Ganglion (SPG) Blockade for the Prevention and Acute Treatment of Migraine

Sarah Bobker, MD, USCF Headache Center

The Probability of Atrial Fibrillation Predicted by an AI-enabled ECG Algorithm in Patients with Migraine with Aura and Migraine without Aura

Nikita Chhabra, DO, Mayo Clinic

Relationship between Intervals of the Menstrual Cycle and Presentation to the Emergency Department for Headache

Crystal Jicha, MD, Montefiore Medical Center

Frontiers in Headache Research Award Poster Presentations
Is Attribution of Blame in Concussion Linked to Post-traumatic Headache?

Caitlin Christensen, MD, University of Alberta

Addressing Mental Health Among Patients with Chronic Headaches to Improve Outcomes, Wellbeing, and Resource Utilization

Kelsey Duncan, MD, Case Western Reserve University/University Hospitals Cleveland Medical Center

Joint Hypermobility Syndrome in Children and Adolescents with Headaches: Retrospective Study

Ankita Ghosh, MD, Cincinnati Children’s Hospital Medical Center

Migraine in Women Undergoing Fertility Treatment: A Prospective Study

Jasmin Harpe, MD, NewYork-Presbyterian Hospital

Diagnostic Delay of Chronic Migraine and Medication Overuse Headache at a Tertiary Care Center in Peru

Farrah Khan, MD, University of Washington

Predictors of Clinical Response to Erenumab in Patients with Migraine

Olga Lekontseva, MD, PhD, University of Calgary

Nerve Blocks for the Treatment of COVID-19 Related Headache

Aarushi Suneja, MD, Cleveland Clinic

6th Annual Migraine Moment Short Film Contest Video Viewing

Migraine: The Invisible Illness That Alters the Lives of Millions

Morgan Fitzgerald

Headache Lounges
Thursday, June 3, 2021
2:00 – 3:00 PM EDT
Basic Science Headache Lounge
Moderators: Gregory Dussor, PhD and Hadas Nahman-Averbuch, PhD
Friday, June 4, 2021
3:15 – 4:15 PM EDT
New Member Headache Lounge
Moderators: Matthew S. Robbins, MD, FAHS and Jaclyn R. Duvall, MD
Saturday, June 5, 2021
3:15 – 4:15 PM EDT
Clinical Headache Lounge
Moderator: Jessica Ailani, MD, FAHS



2021 Virtual Annual Scientific Meeting (63rd)


2021 Virtual Annual Scientific Meeting Registration Fees and Information

Online registration is now open. Click here to register.

AHS Member and Non-member Registration Categories and Fees

Active Member (MD, DO, PhD, DDS) $300.00
Associate Member (RN, NP, PA) $150.00
Trainee Member $75.00
Non-Member (MD, DO, PhD, DDS) $450.00
Non-Member Associate (RN, NP, PA) $200.00
Non-Member Trainee $125.00
Active Military Personnel $75.00
Industry Representative $450.00


Registration Information

Instructions will be sent to the email address provided during registration prior to the anticipated launch date of Thursday, June 3, 2021.

 Acceptable Forms of Payment

Credit cards may be used for all registrations. AHS accepts Visa, MasterCard, and American Express. Charges will appear on your statement as “AHS Registration.”


2021 Virtual Annual Scientific Meeting (63rd)


Exhibit and Sponsorship Information

The Exhibit and Sponsorship portal will allow you to select a sponsorship opportunity (virtual booth included) or purchase a virtual exhibit booth without sponsorship. You will also be able to upload your logo, booth materials, video chat with meeting attendees and much more.

To access the portal, please click here and create an account (click to start button) for the 2021 Virtual Annual Scientific Meeting.

Based on your feedback we are pleased to announce several new features including the availability of a 3D virtual exhibit booth. Additionally, below you will find a summary of the enhancements that we hope you find beneficial for your virtual expo experience:

  • *NEW* 3D Boothcustomizable to provide promotional elements and information to attendees.
  • Banner Advertisementwill appear at the top of the virtual booth and can link to an external URL.
  • Video linka video that provides a short synopsis of your company’s mission or product.
  • Video Chat Roomthose with industry roles can connect with AHS attendees via video chat from the virtual booth.
  • Enhanced Descriptioncan include logo, extended description.
  • Resource Documents (content links / PDF handouts) – provide attendees with material about your company.
  • Exhibit Hall gamification – incentivize meeting attendees to visit your booth.

Through your account, you will have access to all up-to-date information regarding the 2021 Virtual Annual Scientific Meeting. You can also submit payments and manage your account settings through the portal.

Please be prepared to answer a few more questions this year. The Exhibit Review Committee has made some changes to the review process for both previous and new exhibitors.  For example, if you have a new product or device, and have exhibited in the past, you may be asked to submit additional collateral before receiving final approval to exhibit.

Please click here to view exhibit and sponsorship opportunities for the 2021 Virtual Annual Scientific Meeting.

Industry Supported Events

Industry-supported events, CME or non-CME, will be accessible to all meeting registrants via the virtual meeting site. The deadline to submit requests for Industry-Supported Events has passed.


The American Headache Society gratefully acknowledges the support of the 2021 Virtual Annual Scientific Meeting from our industry supporters:


Allergan plc (NYSE: AGN), an AbbVie company (NYSE: ABBV), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world.

Amgen and Novartis logos

In August 2015, Amgen and Novartis entered into a global collaboration to develop and commercialize pioneering treatments in the field of Neuroscience. At the center of the Amgen and Novartis collaboration is the shared mission to fight migraine and the stereotypes and misperceptions surrounding this debilitating disease.

Lilly logo

Lilly was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, is tirelessly dedicated to restoring brain health, so every person can be their best. Lundbeck has a long heritage of innovation in neuroscience and is focused on delivering transformative treatments that address unmet needs in brain health.


Teva logo

Teva Pharmaceuticals is a global leader in generic medicines and biopharmaceuticals. Building on more than a century-old legacy, Teva delivers high-quality products to patients in nearly every therapeutic area, has an established presence in generics, specialty, OTC and API, a fully integrated R&D function, strong operational base and global infrastructure and scale.


Upsher-Smith logo

Upsher-Smith Laboratories, LLC is a trusted U.S. pharmaceutical company. We offer a suite of branded central nervous system (CNS) medications to help patients living with migraine headaches and seizure disorders.


Biohaven Pharmaceuticals logo


Currax Pharmaceuticals LLC
Eli Lilly and Company
Impel NeuroPharma
Theranica Bio-Electronics LTD


Ctrl M Health

AHS gratefully acknowledges the educational grant support of the 2021 Virtual Annual Scientific Meeting from our industry supporters:

AbbVie Inc.
Amgen Inc.
Lilly USA, LLC
Lundbeck LLC



2021 Virtual Annual Scientific Meeting (63rd)



The abstract submission period has passed. Authors will receive acknowledgement of receipt of abstracts via email and notification regarding acceptance on or before May 1, 2021.

Each abstract must include objectives, methods, results and conclusions and is limited to 3300 characters (characters include letters, symbols, punctuation and spaces). Mandatory fields are identified with an (*) in the submission site.  If the data submitted has been presented in total or in large part in the past, please note the date and place of the previous presentation(s).

Abstract Topics are as follows:

  • Basic Science
  • Clinical Presentation/Diagnosis
  • Epidemiology
  • Genetics
  • Headache Education
  • Health Services/Outcomes Research
  • Imaging and Neurophysiology
  • Therapeutics
  • Other Clinical Studies
  • Other

For questions or additional information, please contact AHS Headquarters at 856-423-0043 or ahshq@talley.com.


2021 Virtual Annual Scientific Meeting (63rd)


Welcome to the American Headache Society’s 2021 Virtual Annual Scientific Meeting Press Room. Here you can find the latest news releases related to this scientific forum, as well as press guidelines for media professionals, exhibitors, presenters and satellite symposia organizers.

All media-related questions, including obtaining press passes, can be directed to Lauren Schoener-Gaynor at lschoener-gaynor@talley.com or 856-905-5211.

AHS Press Guidelines


2021 Virtual Annual Scientific Meeting (63rd)


“Frontiers in Headache Research” Scholarship Awards

The American Headache Society announces the availability of up to 10 “Frontiers in Headache Research” Scholarship Awards for the Virtual Annual Scientific Meeting scheduled for June 3-6, 2021.

Recipients will receive complimentary meeting registration and a one-year AHS Trainee membership if not already a member of AHS, or a one-year extension of their existing AHS Trainee membership, and be eligible to receive a stipend up to $1,000 for reimbursement of expenses for food, travel and hotel should the meeting remain an in-person event.

Criteria for selection are based on:

  • The quality of the research proposal/project
  • The potential for the proposal, study or thesis to contribute to the advancement of knowledge and future research in the field of Headache Medicine

Applicant must:

  • Be a Headache Medicine Fellow, Resident and or post-doctoral fellow who is in preparatory, active or completion phase of a basic or clinical research project that is related to headache or cranial nociception
  • Not have won an AHS scholarship within the past 2 years. Past winners within 2 years are not eligible to apply
  • Reside in the United States or Canada

Recipient requirements:

  • The top three selected will be required to present their proposal or results to attendees at the 63rd Annual Scientific Meeting
  • All other recipients will be required to submit a poster for display at the 63rd Annual Scientific Meeting

Thank you for your interest in applying for a “Frontiers in Headache Research” Scholarship Award. The application period has closed and recipients will be notified in the coming weeks.


2021 Virtual Annual Scientific Meeting (63rd)


AHS members are invited to participate in Special Interest Section meetings that will be held virtually via Zoom. Please log into your member account and access the event under “My Profile” for Zoom details.

Date Time (EDT) Section
Monday, May 10, 2021 12:00 – 1:00 pm Complementary and Integrative Medicine
Monday, May 10, 2021 7:00 – 8:00 pm Pediatric-Adolescent Headache
Tuesday, May 11, 2021 6:00 – 7:00 pm Clinical Informatics
Thursday, May 13, 2021 5:00 – 6:00 pm Women’s Health
Thursday, May 13, 2021 7:00 – 8:00 pm Procedural Headache Medicine
Friday, May 14, 2021 5:00 – 6:00 pm Refractory, Inpatient and Emergency Care
Tuesday, May 18, 2021 8:00 – 9:00 pm Advanced Practice Providers
Wednesday, May 19, 2021 5:00 – 6:00 pm Post-traumatic Headache
Thursday, May 20, 2021 8:00 – 9:00 pm New Investigators and Trainees
Friday, May 21, 2021 12:00 – 1:00 pm Behavioral Issues
Monday, May 24, 2021 8:00 – 9:00 pm Methodology, Design, and Statistical Issues
Tuesday, May 25, 2021 6:00 – 7:00 pm Underserved Populations in Headache Medicine
Tuesday, June 1, 2021 7:00 – 8:00 pm CSF Pressure and Volume Disorders
Monday, June 7, 2021 6:00 – 7:00 pm Migraine and Vascular Disorders
Wednesday, June 9, 2021 7:00 – 8:00 pm TMD, Cervical Spine & Orofacial Pain
Wednesday, June 30, 2021 7:00 – 8:00 pm Primary Front Line Headache Care